As of 2025-09-17, the Relative Valuation of Sangamo Therapeutics Inc (SGMO) is (4.19) USD. This relative valuation is based on P/E multiples. With the latest stock price at 0.51 USD, the upside of Sangamo Therapeutics Inc based on Relative Valuation is -916.5%.
The range of the Relative Valuation is (3.57) - (4.33) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 15.6x - 20.6x | 18.1x |
| Forward P/E multiples | 17.0x - 26.6x | 21.8x |
| Fair Price | (3.57) - (4.33) | (4.19) |
| Upside | -795.7% - -943.9% | -916.5% |
| Date | P/E |
| 2025-09-08 | -2.52 |
| 2025-09-05 | -2.61 |
| 2025-09-04 | -2.53 |
| 2025-09-03 | -2.54 |
| 2025-09-02 | -2.57 |
| 2025-08-29 | -2.48 |
| 2025-08-28 | -2.58 |
| 2025-08-27 | -2.57 |
| 2025-08-26 | -2.57 |
| 2025-08-25 | -2.62 |
| 2025-08-22 | -2.79 |
| 2025-08-21 | -2.73 |
| 2025-08-20 | -2.57 |
| 2025-08-19 | -2.67 |
| 2025-08-18 | -2.81 |
| 2025-08-15 | -2.76 |
| 2025-08-14 | -2.57 |
| 2025-08-13 | -2.57 |
| 2025-08-12 | -2.47 |
| 2025-08-11 | -2.10 |
| 2025-08-08 | -2.18 |
| 2025-08-07 | -2.30 |
| 2025-08-06 | -2.53 |
| 2025-08-05 | -2.53 |
| 2025-08-04 | -2.55 |
| 2025-08-01 | -2.68 |
| 2025-07-31 | -2.56 |
| 2025-07-30 | -2.60 |
| 2025-07-29 | -2.72 |
| 2025-07-28 | -2.86 |
| 2025-07-25 | -2.79 |
| 2025-07-24 | -2.85 |
| 2025-07-23 | -2.60 |
| 2025-07-22 | -2.29 |
| 2025-07-21 | -2.36 |
| 2025-07-18 | -2.43 |
| 2025-07-17 | -2.30 |
| 2025-07-16 | -2.29 |
| 2025-07-15 | -2.29 |
| 2025-07-14 | -2.38 |
| 2025-07-11 | -2.34 |
| 2025-07-10 | -2.38 |
| 2025-07-09 | -2.51 |
| 2025-07-08 | -2.44 |
| 2025-07-07 | -2.44 |
| 2025-07-03 | -2.51 |
| 2025-07-02 | -2.55 |
| 2025-07-01 | -2.56 |
| 2025-06-30 | -2.58 |
| 2025-06-27 | -2.58 |